FDA Approved: ZONISAMIDE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for Zonisamide from BluePoint Laboratories (ANDA 077651).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Zonisamide (zonisamide)

Snippet

SUPPL AP for ZONISAMIDE (ZONISAMIDE)